Pedestrians walk in front of a Rite Aid Corp. store in Los Angeles, California, U.S., on Tuesday, Sept. 20, 2016.

Rite Aid's fiscal second-quarter earnings results met Wall Street's expectations, while its revenue slightly surpassed them.

Here's how Rite Aid did compared with what Wall Street analysts polled by Thomson Reuters expected:

Adjusted losses: 1 cent per share vs. 1 cent per shareRevenue: $5.42 billion vs. $5.36 billion

The company reported a net loss of $352.3 million, or 33 cents per share. When stripping out one-time events like the impairment charge, the company reported a loss $7.9 million or 1 cent per share, which was in-line with what analysts polled by Thomson Reuters had expected.

Rite Aid said it incurred $282.6 intangible asset impairment charges related to its pharmacy services segment.

The drugstore chain's revenue hit $5.42 billion, slightly above the $5.36 billion Wall Street had anticipated.

Same-store sales increased 1 percent from the same quarter last year, including a 1.6 percent increase in pharmacy sales and a 0.1 percent decrease in front-end sales.

Rite Aid's adjusted earnings before interest, taxes, depreciation, and amortization were $148.6 million, compared with $136.9 million from the previous year.

(Original source)